论文信息 - Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin - 字舞流文

Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin

M. Lebel | A. Yacobi | E. Masson | D. Moros | B. Levitt | Yoram Cohen | D. Ganes | Claude Lapointe MSc | Z. Abolfathi | Y. Golander | Darlene Doepner | Tamar Blumberg | Y. Cohen